Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Jan 15, 2018; 10(1): 23-30
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.23
Published online Jan 15, 2018. doi: 10.4251/wjgo.v10.i1.23
Ref. | Study design/location | Vitamin D exposure/status/genetics studies | Statistical correlation |
Abnet et al[27] | Cross-sectional study | 25-hydroxyvitamin D serum level | RR = 1.86, 95%CI: 1.35-2.62 |
China | |||
Chen et al[28] | Prospective study | 25-hydroxyvitamin D serum level | ESCC in men: |
China | HR = 1.77, 95%CI: 1.16-2.70 | ||
Lipworth et al[29] | Case-control study | Vitamin D dietary intake | ESCC: |
Italy | OR = 0.58, 95%CI: 0.39-0.86 | ||
Tran et al[30] | Case-control study | Ultraviolet B radiation | ESCC: No association |
Australia | |||
Wang et al[24] | Case-control study | Genetic polymorphisms | ESCC: No association |
China |
Ref. | Study design/location | Vitamin D exposure/status/genetics studies | Statistical correlation | Other |
Tran et al[30] | Case-control study | Cumulative ambient ultraviolet B radiation | EAC risk: OR = 0.59, 95%CI: 0.35-0.99 | |
Australia | EAC risk for every 107 J/m2 increase in radiation: OR = 0.82, 95%CI: 0.72-0.93 | |||
Mulholland et al[32] | Case-control study | Vitamin D dietary intake via food questionnaire | EAC risk: OR = 1.99, 95%CI: 1.03-3.86 | |
Ireland | BE risk: no association | |||
Mayne et al[37] | Case-control study | Vitamin D dietary intake | EAC: no association | |
United States | ||||
Thota et al[38] | Retrospective study of a prospectively collected database | 25-hydroxyvitamin D serum levels | EAC: no association | |
United States | BE with HGD: no association | |||
Abnet et al[36] | Nested case-control study | 25-hydroxyvitamin D serum levels | EAC: no association | |
United States, Finland, China | ||||
Trowbridge et al[43] | Retrospective study | Vitamin D receptor expression | Not assessed | VDR expression decreased with tumor dedifferentiation |
United States | VDR expression lower in neoadjuvant therapy responders | |||
Trowbridge et al[34] | Retrospective study | Vitamin D receptor expression | Not assessed | VDR expression increased in Barrett’s esophagus |
United States | ||||
Zhou et al[35] | Descriptive | Vitamin D receptor expression | Not assessed | VDR expressed in 95% of BE (35/37) |
United States | VDR expressed in 78% of EAC (86/109) | |||
Janmaat et al[25] | Cohort study | Vitamin D receptor polymorphisms | EAC: 2 GT copies: | VDR expression is 2 fold higher in BE as compared to normal esophagus |
Netherlands | OR = 0.50, 95%CI: 0.27-0.96 | |||
BE: 2 GT copies: | ||||
OR = 0.46, 95%CI: 0.26-0.80 | ||||
Chang et al[45] | Case- control study | Vitamin D receptor polymorphisms | EAC: rs2238139 TT: | |
Ireland | OR 0.26, 95% CI: 0.07-0.93 | |||
EAC: rs2107301 TT: | ||||
OR = 0.19, 95%CI: 0.06-0.67 | ||||
Zgaga et al[5] | Meta-analysis | Ultraviolet B radiation | Vitamin D level and overall esophageal cancer: | |
United States | Vitamin D intake | OR = 1.39, 95%CI: 1.03-1.74 | ||
Vitamin D serum levels | Vitamin D intake and EAC: | |||
OR = 1.45; 95%CI: 0.65-2.24 |
- Citation: Rouphael C, Kamal A, Sanaka MR, Thota PN. Vitamin D in esophageal cancer: Is there a role for chemoprevention? World J Gastrointest Oncol 2018; 10(1): 23-30
- URL: https://www.wjgnet.com/1948-5204/full/v10/i1/23.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i1.23